BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22998220)

  • 1. The number of regulatory T cells correlates with hemodynamic improvement in patients with inflammatory dilated cardiomyopathy after immunoadsorption therapy.
    Bulut D; Creutzenberg G; Mügge A
    Scand J Immunol; 2013 Jan; 77(1):54-61. PubMed ID: 22998220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy.
    Dandel M; Wallukat G; Englert A; Lehmkuhl HB; Knosalla C; Hetzer R
    Eur J Heart Fail; 2012 Dec; 14(12):1374-88. PubMed ID: 22892122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of protein A immunoadsorption in patients with advanced chronic dilated cardiomyopathy.
    Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Hardt S; Goeser S; Kaya Z; Katus HA; Dengler TJ
    J Clin Apher; 2009; 24(4):141-9. PubMed ID: 19591221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of immunoglobulin G3 subclass in dilated cardiomyopathy: results from protein A immunoadsorption.
    Staudt A; Dörr M; Staudt Y; Böhm M; Probst M; Empen K; Plötz S; Maschke HE; Hummel A; Baumann G; Felix SB
    Am Heart J; 2005 Oct; 150(4):729-36. PubMed ID: 16209975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus.
    Dandel M; Englert A; Wallukat G; Riese A; Knosalla C; Stein J; Hetzer R
    Atheroscler Suppl; 2015 May; 18():124-33. PubMed ID: 25936316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of morbidity by immunoadsorption therapy in patients with dilated cardiomyopathy.
    Knebel F; Böhm M; Staudt A; Borges AC; Tepper M; Jochmann N; Wernicke KD; Felix S; Baumann G
    Int J Cardiol; 2004 Dec; 97(3):517-20. PubMed ID: 15561342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effect of immunoadsorption and subsequent immunoglobulin substitution in patients with dilated cardiomyopathy: Results from the observational prospective Bad Berka Registry.
    Ohlow MA; Brunelli M; Schreiber M; Lauer B
    J Cardiol; 2017 Feb; 69(2):409-416. PubMed ID: 27890513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of immunoadsorption and subsequent immunoglobulin G substitution on cardiopulmonary exercise capacity in patients with dilated cardiomyopathy.
    Herda LR; Trimpert C; Nauke U; Landsberger M; Hummel A; Beug D; Kieback A; Dörr M; Empen K; Knebel F; Ewert R; Angelow A; Hoffmann W; Felix SB; Staudt A
    Am Heart J; 2010 May; 159(5):809-16. PubMed ID: 20435190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of T cell response to cardiac myosin and a reduced response to PPD in patients with idiopathic dilated cardiomyopathy.
    Bromelow KV; Souberbielle B; Alavi A; Goldman JH; Libera LD; Dalgleish AG; McKenna WJ
    J Autoimmun; 1997 Apr; 10(2):219-27. PubMed ID: 9185883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of protein A immunoadsorption on T cell activation in patients with inflammatory dilated cardiomyopathy.
    Bulut D; Scheeler M; Wichmann T; Börgel J; Miebach T; Mügge A
    Clin Res Cardiol; 2010 Oct; 99(10):633-8. PubMed ID: 20419455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study to assess the use of protein a immunoadsorption for chronic dilated cardiomyopathy.
    Cooper LT; Belohlavek M; Korinek J; Yoshifuku S; Sengupta PP; Burgstaler EA; Winters JL
    J Clin Apher; 2007; 22(4):210-4. PubMed ID: 17385721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of immunoadsorption on endothelial function, circulating endothelial progenitor cells and circulating microparticles in patients with inflammatory dilated cardiomyopathy.
    Bulut D; Scheeler M; Niedballa LM; Miebach T; Mügge A
    Clin Res Cardiol; 2011 Jul; 100(7):603-10. PubMed ID: 21298435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a repeated immunoadsorption in patients with dilated cardiomyopathy after recurrence of severe heart failure symptoms.
    Reinthaler M; Empen K; Herda LR; Schwabe A; Rühl M; Dörr M; Felix SB
    J Clin Apher; 2015 Aug; 30(4):217-23. PubMed ID: 25346275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapy.
    Ameling S; Herda LR; Hammer E; Steil L; Teumer A; Trimpert C; Dörr M; Kroemer HK; Klingel K; Kandolf R; Völker U; Felix SB
    Eur Heart J; 2013 Mar; 34(9):666-75. PubMed ID: 23100283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy.
    Staudt A; Staudt Y; Hummel A; Empen K; Dörr M; Trimpert C; Birkenmeier K; Kühl U; Noutsias M; Russ D; Felix SB
    Ther Apher Dial; 2006 Feb; 10(1):42-8. PubMed ID: 16556135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antibodies obtained from patients with dilated cardiomyopathy on the function of isolated rat hearts.
    Staudt Y; Trimpert C; Birkenmeier K; Krieg T; Bemmann T; Beug D; Felix SB; Staudt A
    Eur J Clin Invest; 2006 Feb; 36(2):85-90. PubMed ID: 16436089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoadsorption in dilated cardiomyopathy.
    Staudt A; Felix SB
    Transfus Apher Sci; 2007 Oct; 37(2):187-90. PubMed ID: 18036989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoadsorption as treatment option in dilated cardiomyopathy.
    Felix SB; Staudt A
    Autoimmunity; 2008 Sep; 41(6):484-9. PubMed ID: 18781476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution.
    Staudt A; Schäper F; Stangl V; Plagemann A; Böhm M; Merkel K; Wallukat G; Wernecke KD; Stangl K; Baumann G; Felix SB
    Circulation; 2001 Jun; 103(22):2681-6. PubMed ID: 11390337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of evidence for a pathogenic role of proteasome-directed autoimmunity in dilated cardiomyopathy.
    Voigt A; Trimpert C; Bartel K; Egerer K; Kuckelkorn U; Feist E; Gericke C; Klingel K; Kandolf R; Felix SB; Baumann G; Kloetzel PM; Stangl K; Staudt A
    Basic Res Cardiol; 2010 Jul; 105(4):557-67. PubMed ID: 20336303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.